ArticleJournal of medicinal chemistryPublished
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease
Regional connection
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
- Institution
- Merck & Co.
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Journal of medicinal chemistry
- Published
- Topic
- Disease research
- Subject terms
- Brain; Animals; Humans; Parkinson Disease; Macrocyclic Compounds; Protein Kinase Inhibitors; Structure-Activity Relationship; Drug Discovery; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
- PubMed ID
- 41906303
- Added to directory
- Source checked